Investing.com - Immunocore Holdings (NASDAQ: IMCR) reported first quarter EPS of £-0.43, £0.14 worse than the analyst estimate of £-0.29. Revenue for the quarter came in at £55.09M versus the consensus estimate of £40.37M.
Immunocore Holdings's stock price closed at £59.75. It is down -3.21% in the last 3 months and up 134.68% in the last 12 months.
Immunocore Holdings saw 1 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Immunocore Holdings's stock price’s past reactions to earnings here.
According to InvestingPro, Immunocore Holdings's Financial Health score is "good performance".
Check out Immunocore Holdings's recent earnings performance, and Immunocore Holdings's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar